May 2018;297(5):1081-1088
Benefits of BCAA
In the SURMOUNT-1 trial of tirzepatide, participants on the 15 milligram dose lost an average of 20.9 percent of their body weight over 72 weeks, while the STEP 1 trial of once-weekly semaglutide reported about 14.9 percent over 68 weeks
From maintenance struggles and fear of weight regain to identity shifts, food noise, and long-term Zepbound, Wegovy, Mounjaro, semaglutide, and tirzepatide use, this honest and humorous conversation explores what happens after you reach your goal weight
DIETARY PATTERNS & PROTEINS TO SUPPORT GLP-1RAs Without doubt, both dietary eating patterns and a protein-forward menu plan directly affect how well prescriptive GLP-1 receptor agonist work
Safe, inexpensive, and well-tolerated